Please note that the contents in this webpage are current as of the date of the announcement and the information including but not limited to the product availability, specification, prices, contacts, are subject to change without prior notice.

• 2025.04.07

  • Information
  • News Release

  Further Enhancements Added to the “onti” Medical Isotope Exposure Dose Management System

• 2025.03.31

  • Information

  PDRadiopharma Host Joint Seminar at The 84th Annual Meeting of the Japanese Society, and Exhibit at the International Technical Exhibition of Medical Imaging 2025

• 2025.03.28

  • News Release

  New Radiopharmaceuticals for Renal Cell Carcinoma -Assessing the potential of PD-32766 as a PET diagnostic and raising expectations for novel diagnostic and therapeutic agents in nuclear medicine-（National Cancer Center／PeptiDream Inc.）

• 2025.03.28

  Announcement of New Management Structure

• 2025.03.21

  PeptiDream Featured in a Video Produced by the Prime Minister’s Office of Japan（PeptiDream Inc.)

• 2025.03.17

  • News Release

  New Functionality Added to the “onti” Medical Isotope Exposure Dose Management System

• 2025.02.17

  • Information

  Financial Results Presentation (Fiscal Year Ending December 2024)（PeptiDream Inc.）

• 2025.02.14

  Consolidated Financial Results for the Fiscal Year Ended December 31, 2024 [IFRS]（PeptiDream Inc.）

• 2025.02.13

  • News Release

  PeptiDream Awarded Prime Status in ISS ESG Corporate Rating for the First Time（PeptiDream Inc.）

• 2025.01.16

  • News Release

  “Bridgea GATEWAY” and “onti” Pass the IHE-J2024 Connectathon Interoperability Test